Skip to main content
Lixisenatide product
Metabolic Pathway Research ·

LixisenatideLyxumia; Adlyxin; AVE0010

0 papers·Previously FDA-approved; discontinued 2023·COA Unverified·0 saved

Vendors

0 vendors / 0 options$0.00–$0.00/mg
VendorTierPurityCOA$/mg

Reference

Regulatory Status
USResearch only
EUNot approved
UKResearch only
AUResearch only

Regulatory status may change. Always verify current regulations in your jurisdiction before purchase.